Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the efficacy of ZD6474 when given orally to patients with
relapsed multiple myeloma. A minimum of 15 and a maximum of 30 evaluable patients will be
entered on study